Cargando…
Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database
Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631251/ https://www.ncbi.nlm.nih.gov/pubmed/34873506 http://dx.doi.org/10.7759/cureus.19163 |
_version_ | 1784607515895398400 |
---|---|
author | Dahl, Mary Aurit, Sarah J Silberstein, Peter T Gootee, Jonathan |
author_facet | Dahl, Mary Aurit, Sarah J Silberstein, Peter T Gootee, Jonathan |
author_sort | Dahl, Mary |
collection | PubMed |
description | Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance of the primary anatomic sites. Methods: The study cohort included 2,278 patients diagnosed with fibrosarcoma who received surgery from the NCDB. Kaplan-Meier curves, log-rank tests, and a multivariable Cox proportional hazard model were used to analyze the significance of factors affecting overall survival. Results: The head, face, and neck (HR = 1.44; 95% CI: 1.01-2.05; P = 0.046) and thorax anatomical sites (HR = 1.33; 95% CI: 1.02-1.73; P = 0.035) had a higher increased risk of death in comparison to the lower limb and hip. Compared to patients with private insurance, patients without insurance (HR = 1.99; 95% CI: 1.22 to 3.25; P = 0.006) and patients with Medicaid (HR = 1.99; 95% CI: 1.37 to 2.90; P < 0.001) had decreased overall survival. Patients associated with a zip code-level median household income ≥ $63,000 had a decreased risk of mortality when compared to lower income groups. Conclusion: In general, older patients with comorbidities, advanced-stage disease, and larger tumors who did not have private insurance and were from areas associated with lower income levels had poorer overall survival. No significant difference in overall survival was associated with receipt of neoadjuvant chemotherapy or neoadjuvant radiation. |
format | Online Article Text |
id | pubmed-8631251 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cureus |
record_format | MEDLINE/PubMed |
spelling | pubmed-86312512021-12-05 Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database Dahl, Mary Aurit, Sarah J Silberstein, Peter T Gootee, Jonathan Cureus Oncology Purpose: Fibrosarcoma (FS) is a rare and malignant tumor that can occur in a variety of anatomic sites. The goal of this study is to use the National Cancer Database (NCDB) to analyze various factors affecting overall survival in FS and to be one of the rare studies to characterize the significance of the primary anatomic sites. Methods: The study cohort included 2,278 patients diagnosed with fibrosarcoma who received surgery from the NCDB. Kaplan-Meier curves, log-rank tests, and a multivariable Cox proportional hazard model were used to analyze the significance of factors affecting overall survival. Results: The head, face, and neck (HR = 1.44; 95% CI: 1.01-2.05; P = 0.046) and thorax anatomical sites (HR = 1.33; 95% CI: 1.02-1.73; P = 0.035) had a higher increased risk of death in comparison to the lower limb and hip. Compared to patients with private insurance, patients without insurance (HR = 1.99; 95% CI: 1.22 to 3.25; P = 0.006) and patients with Medicaid (HR = 1.99; 95% CI: 1.37 to 2.90; P < 0.001) had decreased overall survival. Patients associated with a zip code-level median household income ≥ $63,000 had a decreased risk of mortality when compared to lower income groups. Conclusion: In general, older patients with comorbidities, advanced-stage disease, and larger tumors who did not have private insurance and were from areas associated with lower income levels had poorer overall survival. No significant difference in overall survival was associated with receipt of neoadjuvant chemotherapy or neoadjuvant radiation. Cureus 2021-10-31 /pmc/articles/PMC8631251/ /pubmed/34873506 http://dx.doi.org/10.7759/cureus.19163 Text en Copyright © 2021, Dahl et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Oncology Dahl, Mary Aurit, Sarah J Silberstein, Peter T Gootee, Jonathan Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title | Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title_full | Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title_fullStr | Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title_full_unstemmed | Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title_short | Primary Site and Other Prognostic Factors for Fibrosarcoma: An Analysis of the National Cancer Database |
title_sort | primary site and other prognostic factors for fibrosarcoma: an analysis of the national cancer database |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8631251/ https://www.ncbi.nlm.nih.gov/pubmed/34873506 http://dx.doi.org/10.7759/cureus.19163 |
work_keys_str_mv | AT dahlmary primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase AT auritsarahj primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase AT silbersteinpetert primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase AT gooteejonathan primarysiteandotherprognosticfactorsforfibrosarcomaananalysisofthenationalcancerdatabase |